Diamond Pharma Services Acquires PharmaCentral to Strengthen Pharmacovigilance Division
Acquisition expands presence in Europe and enhances senior-level expertise
Diamond Pharma Services, a leading technical services and regulatory affairs consulting group, today announced its pharmacovigilance division, Diamond PV Services, has acquired PharmaCentral, an innovative pharmacovigilance services and medical affairs business based in Dublin, Ireland. The acquisition will expand Diamond’s presence in Europe and enhance the senior-level expertise within its pharmacovigilance team.
PharmaCentral offers a wide range of pharmacovigilance consultancy services, based on a wealth of experience in pharmacovigilance and medical affairs in both pharma and CRO environments. The acquisition of PharmaCentral forms part of Diamond’s growth strategy for its pharmacovigilance division, which has achieved a Compound Annual Growth Rate (CAGR) in revenues of 27% over the last three years. This rapid expansion of Diamond’s pharmacovigilance senior level team is required to support clients from Diamond’s regulatory affairs business in specialist areas such as gene and cell therapies.